CD44 and breast carcinoma: In a study with breast cancer cells (MDA-MB-231, MDA-MB-436, Hs578T, SUM1315, and HBL-100 cell lines) having CD44+/CD24− subpopulation showed higher levels of expression of proinvasive genes and had highly invasive properties [58].